Project Grant R01AT013980
- The Department of Health and Human Services National Institutes of Health Office of the Director awarded Beth Israel Deaconess Medical Center, Inc. (BIDMC) $637,845 on June 19, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds a remote, randomized controlled study assessing the efficacy of mindfulness apps for people with depression using precision medicine methodology. The research compares participants randomized to...
- The National Center for Complementary and Integrative Health (NCCIH), part of the Department of Health and Human Services National Institutes of Health, awarded $133,236 to Massachusetts General Hospital on August 4, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to develop and validate a tailored digital mindfulness intervention for emerging adults experiencing problematic social media use and anxiety symptoms. The award funds development...
- The National Center for Complementary and Integrative Health (part of the Department of Health and Human Services National Institutes of Health) awarded $164,268 to the University of Washington on April 15, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to optimize mindfulness-based cognitive therapy practice for chronic pain in people with multiple sclerosis. The award funds a K23 career development project running through March 31, 2031,...
- The National Institute on Drug Abuse awarded Yale University $757,563 on August 1, 2026, to develop and pilot-test a digital intervention called Emotion Regulation via Breathing (EB) for reducing stress-related opioid misuse under the Drug Use and Addiction Research Programs (CFDA 93.279). The project addresses the interplay between stress, chronic pain, and opioid misuse by creating a four-week digital program that teaches self-regulated breathing skills to improve emotion regulation and...
- The National Institute on Drug Abuse awarded the University of California, Los Angeles $376,398 on April 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate a digital therapeutic application for comorbid anxiety disorders and alcohol or cannabis use disorders. The recipient will conduct an iterative, human-centered design process to develop a mobile application-based intervention called Anxiety Management Treatment for Substance Use Disorders...
- The National Institute on Drug Abuse awarded $314,109 to Behavior Change Hub Limited Liability Company on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop the Addiction Application Gradebook, a web platform for organizing, describing, evaluating, and tracking smartphone and web-based applications addressing substance use disorder. The Phase I Small Business Technology Transfer project will establish research and development foundations across three...
- This Project Grant award of $125,026 from the National Center for Complementary and Integrative Health (CFDA 93.213 - Research and Training in Complementary and Integrative Health) will fund research conducted by the Massachusetts Institute of Technology (MIT) to investigate the brain bases of mindfulness. The project aims to: 1) identify reliable brain network connections that predict trait mindfulness using resting-state fMRI data from over 350 adults, and 2) examine state mindfulness and...
- The National Center for Complementary and Integrative Health (NCCIH), within the Department of Health and Human Services National Institutes of Health, awarded Duke University a $1,980,122 cooperative agreement on April 23, 2026, to conduct a multicenter randomized controlled trial (RCT) testing the efficacy of LIFT, a self-directed mobile mindfulness intervention designed to reduce psychological distress in cardiorespiratory failure survivors. The award funds a 4-site multicenter RCT with...
- The National Institute on Drug Abuse awarded Yale University $336,250 on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a behavioral foundation model that transforms qualitative epidemiological survey responses into quantitative representations of substance use behaviors. The project harmonizes data from the National Epidemiologic Survey on Alcohol and Related Conditions III (NESARC-III), National Survey on Drug Use and Health (NSDUH), and UK Biobank...
- The National Institutes of Health National Center for Complementary and Integrative Health awarded New York University $785,637 under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) from June 2021 through May 2025. This Cooperative Agreement will support the development and pilot testing of telephone-delivered and video-based Mindfulness-Based Cognitive Therapy (MBCT) protocols for patients with migraine headaches and depressive symptoms. Specifically, the...
The National Center for Complementary and Integrative Health, within the Department of Health and Human Services National Institutes of Health, awarded Yale University $634,664 on August 28, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) to conduct a multi-site feasibility trial of smartphone-based mindfulness treatment for promoting addiction recovery. The award funds development and testing of a digital mindfulness-based treatment designed as an aftercare intervention for substance use disorders. The project addresses high relapse rates following intensive addiction treatment and targets individuals who do not respond to existing evidence-based aftercare options such as cognitive-behavioral therapy and twelve-step facilitation. The smartphone application delivers mindfulness meditation training tailored specifically for substance use disorders, employing user-centered design principles incorporating feedback from people with lived experience of addiction. This disorder-specific digital approach aims to increase accessibility to mindfulness-based treatment by eliminating the need for trained providers while maintaining the therapeutic effectiveness documented in existing aftercare mindfulness research. Performance occurs in New Haven, Connecticut, with the period of performance extending from August 28, 2026, through July 31, 2029. The award is structured as a Project Grant, the assistance type used by NIH for research projects.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $634.7k | 9/1/26 |